Mercury (Hobart)

PBS listing offers hope for eczema sufferers

- CAMERON WHITELEY cameron.whiteley@news.com.au

SUFFERERS of severe eczema, such as Tasmanian Jessie Dallas, will have improved access to a medicine to treat the skin condition.

Federal Health Minister Greg Hunt has announced that from March 1, Dupixent will be available to Australian­s over 12 living with eczema, also known as atopic dermatitis, who are not adequately controlled by other therapy.

Mr Hunt said more than $270m was being invested to put the medicine on the Pharmaceut­ical Benefits Scheme, with more than 3600 people expected to benefit each year.

Without the PBS subsidy, sufferers might otherwise pay about $22,800 a year.

Mrs Dallas, 37, said eczema had a significan­t impact on her physical and mental wellbeing.

“I have been hospitalis­ed twice where they had to cover me in bandages and I have had many days when I have not been able to move because of the searing pain,’’ she said.

“I was avoiding showers and was unable to sleep because I would frequently get itching attacks. It also made exercising extremely uncomforta­ble.”

But in 2019, after trying many other medication­s, she started treatment with Dupixent on compassion­ate grounds.

“It’s significan­tly improved my quality of life … it’s nowhere near as painful, I’m not itching anywhere near as much and I’m looking much better compared to what I used to look like,'’ she said.

Mrs Dallas has the treatment through a fortnightl­y injection into the stomach.

Mr Hunt said uncontroll­ed eczema was more than a skin condition and could affect every aspect of life for individual­s and their families.

“While there is no known cure for eczema, medicines such as Dupixent can offer relief to people from debilitati­ng symptoms and improve quality of life,’’ he said.

“Dupixent is a targeted new medicine that stops the body’s immune system overreacti­ng and producing more inflammati­on than is normal.

“Until now, treatment of severe atopic dermatitis has focused on reducing inflammati­on through use of intensive topical skin treatments and broadbased systemic immunosupp­ressant therapies that can have widespread effects on the body.”

Newspapers in English

Newspapers from Australia